Sonitus Medical markets the SoundBite Hearing System, an almost invisible in-the-mouth hearing and communication platform that transmits sound via the teeth using bone conduction. The device is targeted to patients with Single-Sided Deafness and Conductive Hearing Loss and is offered by otolaryngologists and audiologists in the US and Canada. Founded in 2006 and based in San Mateo, California, the company is privately held. Sonitus intends to use recent financing primarily for additional working capital as it expands commercialization efforts. Company leadership said GE Capital provided a flexible lending structure to support ramping product development and commercialization. The financing is a senior secured multi-draw term loan intended to support the company’s ongoing commercial expansion. Sonitus Medical develops and manufactures SoundBite, a non-surgical, removable hearing device that transmits sound via the teeth. The device has received FDA 510(k) clearance for single-sided deafness and conductive hearing loss. The company plans to expand marketing of the SoundBite system in the U.S. using proceeds from its latest financing. Sonitus is based in San Mateo, CA, was founded in June 2006, and is led by CEO Amir Abolfathi. It recently closed a $25M Series D to fund those commercial efforts. In conjunction with the round, Abingworth partner David Mayer joined the company's board of directors.

Total raised

$35M

Funding rounds

2

Latest round

Debt Financing

Latest activity

Sep 2013